Recommendation: Hold PLTR for now.

Rationale
- The provided plan emphasizes that near-term progress on commercial ARR, cross-sell velocity, and gross margins remains uncertain. Given data gaps and ongoing government/regulatory exposure, the risk/return favors patience until credible, data-backed improvements are visible.
- The bull case remains plausible (Foundry/AIP, Lumen cross-sell, durable moat), but the absence of verifiable ARR/margin progress keeps the premium valuation hard to justify at this moment.
- Maintaining a Hold keeps you positioned for a decisive re-rating if and when the next few quarters demonstrate durable ARR growth, stronger commercial mix, and margin expansion.

Data-driven framework to monitor (8-indicator set and beyond)
- 8-indicator data set: close_50_sma, close_200_sma, close_10_ema, macd, macds, rsi, boll_ub, atr
- Momentum signals to watch for a Buy signal (conditions push toward a staged entry):
  - Price trades above both 50-day and 200-day SMAs (positive longer-term trend alignment)
  - MACD line crosses above the signal line with increasing histogram
  - RSI moving into a constructive zone (e.g., 50–70) without becoming overbought
  - Price tests or approaches the upper Bollinger Band with disciplined volatility (ATR confirming gradual expansion)
- If these indicators align with improving fundamentals over 1–2 quarters (ARR growth, commercial mix shift, gross margin improvement, acceleration from Lumen), prepare a staged Buy with predefined entry tiers and risk guards.

Actionable steps if you already hold PLTR
- Keep exposure but tighten risk controls:
  - Establish a stop based on a multiple of ATR from recent swing lows plus a price-based guard near key supports.
  - Consider a hedged approach (e.g., collar or a modest put hedge) to cap downside while preserving upside if data turns constructive.
- If you do not have a position yet, wait for the data signals above before initiating new buys; avoid averaging in ahead of clear momentum confirmation.

Catalysts to watch (timing and impact)
- Quarterly earnings commentary focusing on ARR, bookings mix, gross margins, and progress of commercial AI deployments.
- Lumen partnership deployment cadence and cross-sell outcomes across large accounts.
- Regulatory headlines and any shifts in government versus commercial revenue mix.

Scenario planning and review cadence
- Base case: modest ARR growth with stable gross margins and steady cross-sell progress; hold until data validate upside.
- Upside: durable ARR acceleration, meaningful margin expansion, positive Lumen-driven cross-sell momentum.
- Downside: delayed commercial ramp, mixed signals from 8-indicator set, or new headwinds; reduce exposure or exit if momentum deteriorates.

Next steps (your choice)
- I can re-run the 8-indicator analysis now and deliver a data-backed pathway to a potential Buy with precise entry levels, stop placement, and sizing.
- Or, I can provide the outlined framework now and fill in the indicator readings and trade specifics once the data return.

Bottom line
- Hold remains the disciplined stance given the current data gaps and risk factors. A Buy would be warranted only after observable, verifiable improvements in ARR, gross margins, and cross-sell velocity, plus constructive momentum signals from the 8-indicator set.

FINAL TRANSACTION PROPOSAL: **HOLD**